(Q33850220)

English

Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

Peter P Nawroth

7

object named as

Peter P Nawroth

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Angelika Bierhaus

5

object named as

Angelika Bierhaus

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

9

object named as

Hugo A Katus

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Samuel Morris-Rosenfeld

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Erwin Blessing

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Michael R Preusch

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Claudia Albrecht

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Martin Andrassy

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Michael E Rosenfeld

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Florian Bea

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

21 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

European Journal of Clinical Investigation

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1164-1171

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

Innate immunity, macrophage activation, and atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

RAGE signaling sustains inflammation and promotes tumor development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

Glycated LDL increases monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated chemotaxis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

A new mathematical model for relative quantification in real-time RT-PCR

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

Hypercholesterolemia contributes to the development of atherosclerosis and vascular remodeling by recruiting bone marrow-derived cells in cuff-induced vascular injury.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

New Markers of Inflammation and Endothelial Cell Activation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

Adult progenitor cells in vascular remodeling during atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02514.X

21 January 2018

Identifiers

10.1111/J.1365-2362.2011.02514.X

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33850220&oldid=1957014159"